AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)
Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –
AtriCure cash
Cash and short-term investments held at the end of each period.
AtriCure's cash was $167.79M at Jun 30, 2026. For fiscal 2025 it was $167.43M, up 36.4% from the year before. Over ten years it grew 17.1% a year on average. The highest annual figure on record is $244.22M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $167.43M | +36.4% |
| FY2024 | Dec 31, 2024 | $122.72M | -10.6% |
| FY2023 | Dec 31, 2023 | $137.29M | +13.4% |
| FY2022 | Dec 31, 2022 | $121.11M | +1.7% |
| FY2021 | Dec 31, 2021 | $119.09M | -51.2% |
| FY2020 | Dec 31, 2020 | $244.22M | +198.6% |
| FY2019 | Dec 31, 2019 | $81.80M | -34.2% |
| FY2018 | Dec 31, 2018 | $124.40M | +261.1% |
| FY2017 | Dec 31, 2017 | $34.45M | -21.7% |
| FY2016 | Dec 31, 2016 | $44.01M | +27.3% |
| FY2015 | Dec 31, 2015 | $34.58M | -42.0% |
| FY2014 | Dec 31, 2014 | $59.65M | +127.6% |
| FY2013 | Dec 31, 2013 | $26.21M | +118.4% |
| FY2012 | Dec 31, 2012 | $12.00M | -15.4% |
| FY2011 | Dec 31, 2011 | $14.18M | +12.8% |
| FY2010 | Dec 31, 2010 | $12.57M | +41.2% |
| FY2009 | Dec 31, 2009 | $8.91M | -22.2% |
| FY2008 | Dec 31, 2008 | $11.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $167.79M | +42.4% |
| Q1 FY2026 | Mar 31, 2026 | $146.17M | +46.3% |
| Q4 FY2025 | Dec 31, 2025 | $167.43M | +36.4% |
| Q3 FY2025 | Sep 30, 2025 | $147.87M | +13.4% |
| Q2 FY2025 | Jun 30, 2025 | $117.80M | +3.3% |
| Q1 FY2025 | Mar 31, 2025 | $99.89M | -5.7% |
| Q4 FY2024 | Dec 31, 2024 | $122.72M | -10.6% |
| Q3 FY2024 | Sep 30, 2024 | $130.34M | -2.0% |
| Q2 FY2024 | Jun 30, 2024 | $114.02M | -10.2% |
| Q1 FY2024 | Mar 31, 2024 | $105.96M | -22.0% |
| Q4 FY2023 | Dec 31, 2023 | $137.29M | +13.4% |
| Q3 FY2023 | Sep 30, 2023 | $133.01M | +8.5% |
| Q2 FY2023 | Jun 30, 2023 | $127.03M | +7.2% |
| Q1 FY2023 | Mar 31, 2023 | $135.86M | +22.0% |
| Q4 FY2022 | Dec 31, 2022 | $121.11M | +1.7% |
| Q3 FY2022 | Sep 30, 2022 | $122.64M | +2.4% |
| Q2 FY2022 | Jun 30, 2022 | $118.45M | -25.9% |
| Q1 FY2022 | Mar 31, 2022 | $111.40M | -51.0% |
| Q4 FY2021 | Dec 31, 2021 | $119.09M | -51.2% |
| Q3 FY2021 | Sep 30, 2021 | $119.75M | -48.6% |
| Q2 FY2021 | Jun 30, 2021 | $159.87M | -31.2% |
| Q1 FY2021 | Mar 31, 2021 | $227.21M | +231.5% |
| Q4 FY2020 | Dec 31, 2020 | $244.22M | +198.6% |
| Q3 FY2020 | Sep 30, 2020 | $233.07M | +192.3% |
| Q2 FY2020 | Jun 30, 2020 | $232.50M | +155.9% |
| Q1 FY2020 | Mar 31, 2020 | $68.54M | -31.9% |
| Q4 FY2019 | Dec 31, 2019 | $81.80M | -34.2% |
| Q3 FY2019 | Sep 30, 2019 | $79.74M | +98.3% |
| Q2 FY2019 | Jun 30, 2019 | $90.84M | +145.1% |
| Q1 FY2019 | Mar 31, 2019 | $100.63M | +179.2% |
| Q4 FY2018 | Dec 31, 2018 | $124.40M | +261.1% |
| Q3 FY2018 | Sep 30, 2018 | $40.22M | +17.0% |
| Q2 FY2018 | Jun 30, 2018 | $37.07M | +6.0% |
| Q1 FY2018 | Mar 31, 2018 | $36.04M | +4.6% |
| Q4 FY2017 | Dec 31, 2017 | $34.45M | -21.7% |
| Q3 FY2017 | Sep 30, 2017 | $34.39M | -16.8% |
| Q2 FY2017 | Jun 30, 2017 | $34.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.47M | – |
| Q4 FY2016 | Dec 31, 2016 | $44.01M | – |
| Q3 FY2016 | Sep 30, 2016 | $41.34M | – |
See a number that looks wrong?